Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat - Intravital microscope studies

Cephalalgia

Volumn 17, Issue 4, 1997, Pages 525-531

  Williamson, D J ^a   Hargreaves, R J ^a   Hill, R G ^a   Shepheard, S L ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Calcitonin gene related peptide; Intravital microscopy; Middle meningeal artery; Migraine; Sumatriptan; Trigeminal

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; SUBSTANCE P; SUMATRIPTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL DIAMETER; BRAIN BLOOD FLOW; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROSCOPY; MIDDLE CEREBRAL ARTERY; MIGRAINE; NONHUMAN; RAT; VASODILATATION;

AFFERENT PATHWAYS; ANESTHETICS; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DURA MATER; ELECTRIC STIMULATION; INDOLES; MALE; MICROSCOPY, VIDEO; NERVE FIBERS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P; SUMATRIPTAN; TRIGEMINAL NERVE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0030977313     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1704525.x     Document Type: Article

References (30)

1. Ray BS, Wolff HG. Experimental studies on headache: pain sensitive structures of the head and their significance in headache. Arch Surg 1940;41:813-56
2. Penfield W, McNaughton F. Durai headache and innervation of the dura mater. Arch Neurol Psychiatry 1940;44:43-75
3. Uddman R, Edvinsson L. Neuropeptides in the cerebral circulation. Cerebrovasc Brain Metab Rev 1989;1:230-52
4. Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, Edvinsson L. Distribution and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 1992;13:527-36
5. Saito K, Markowitz S, Moskowitz MA. Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol 1988;24:732-7
6. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990;99:202-6
7. 1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 1991;11:165-8
8. 1-like receptor. Cephalalgia 1992;12:202-5
9. 1-like receptors mediate 5-hydroxytryptamine-induced contractions of the human isolated basilar artery. Br J Pharmacol 1989;96:434-49
10. Humphrey PPA, Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 1991;12: 444-6
11. (8-37) antagonizes the cerebral vasodilator response from nasociliary nerve stimulation in the cat. Neurosci Lett 1993;151:13-6
12. Kurosawa M, Messlinger K, Pawlak M, Schmidt RF. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 1995;114:1397-402
13. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Direct measurement of durai vessel diameter in the rat using intravital microscopy. Br J Pharmacol 1996;117:271P
14. Messlinger KB, Pawlak M, Kurosawa M, Carmody JJ. Calcitonin gene-related peptide, but not substance P, mediates the increased meningeal blood flow elicited by electrical stimulation of rat dura mater encephali. In: Olesen J, Moskowitz MA, editors. Experimental headache models. Philadelphia: Lippincott-Raven Publishers, 1995:101-5
15. Uddman R, Hara H, Edvinsson L. Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunohistochemistry. J Auton Nerv Syst 69-75
16. Keller JT, Marfurt CF. Peptidergic and serotonergic innervation of the rat dura mater. J Comp Neurol 1991;309:551-4
17. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988;23:193-6
18. 1 receptor antagonist RP67580 blocks neurogenic plasma extravasation in the dura mater of rats. Br J Pharmacol 1993;108:11-12
19. Diener HC for the RPR100893-201 migraine study group. Substance-P antagonist RPR100893-201 is not effective in human migraine attacks. 6th International Headache Research Seminar, 17-19 November 1995, Copenhagen, Denmark
20. Goldstein D. Clinical trials of tachykinin antagonists. IBC Conference on Tachykinins and their Antagonists, 10-11 October 1996, London, UK
21. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992;13:307-11
22. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-7
23. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56
24. 1D serotonin receptors in rat: structural and pharmacological comparison of the two cloned receptors. Molec Cell Neurosci 1992;3:578-87
25. 1Db. Proc Natl Acad Sci 1992;89:3630-4
26. 1D receptors. NS Arch Pharmacol 1989;340:135-8
27. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJN, Baber NS. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol 1991;31:291-4
28. Humphrey PPA, Connor HE, Stubbs CM, Feniuk W. Effect of sumatriptan on pial vessel diameter in vivo. In: Olesen J, editor. Migraine and other headaches: the vascular mechanisms. New York: Raven Press, 1991:335-8
29. Knudsen GM, Juhler M, Paulson OB. Morphology, physiology and pathophysiology of the blood brain barrier. In: Olesen J, Edvinsson L, editors. Basic mechanisms of headache. Elsevier Science Publishers, 1988:49-60
30. 1 antagonist CP-99,994 on plasma extravasation in the dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 1995;34:255-61